Basic information
Biomarker: TATI
Histology type: endometrial carcinoma
Cohort characteristics
Country: Poland
Region: Warsaw
Followed up time :
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 317 | EC | 317 |
Sample information
Conclusion: TATI seems to behave as a prognostic factor in certain subgroups of patients with endometrial cancer.
Sample type : serum
Sample method: immunohistochemistry
Expression pattern : Levels up to 21 µg/L were adopted as reference values for the TATI marker.
Disease information
Statictics: Mean (SD);Range
Cohort age: 60.5;32-81
Related information
UniProt Link:
Molecular function from UniProt:
